ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 93 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $332,290 | +21689.5% | 47,000 | -57.6% | 0.00% | -50.0% |
| Q1 2024 | $1,525 | -12.1% | 110,900 | -41.2% | 0.00% | -33.3% |
| Q4 2023 | $1,734 | -24.5% | 188,500 | -50.4% | 0.00% | -25.0% |
| Q3 2023 | $2,298 | -13.8% | 379,800 | +10.5% | 0.00% | 0.0% |
| Q2 2023 | $2,667 | +36.0% | 343,700 | -0.1% | 0.00% | +33.3% |
| Q1 2023 | $1,961 | +5.1% | 344,100 | +8.6% | 0.00% | 0.0% |
| Q4 2022 | $1,866 | -99.9% | 316,800 | -21.1% | 0.00% | +50.0% |
| Q3 2022 | $1,284,000 | -36.0% | 401,400 | -10.4% | 0.00% | 0.0% |
| Q2 2022 | $2,006,000 | +71.5% | 447,869 | +104.4% | 0.00% | +100.0% |
| Q1 2022 | $1,170,000 | +202.3% | 219,100 | +733.1% | 0.00% | – |
| Q4 2021 | $387,000 | – | 26,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 496,893 | $16,760,000 | 14.90% |
| Svennilson Peter | 4,768,181 | $160,831,000 | 13.45% |
| Invus Financial Advisors, LLC | 1,007,576 | $33,986,000 | 12.28% |
| EcoR1 Capital, LLC | 2,642,218 | $89,122,000 | 6.58% |
| Foresite Capital Management IV, LLC | 125,000 | $4,216,000 | 2.05% |
| Orbimed Advisors | 2,921,967 | $98,558,000 | 1.39% |
| Casdin Capital, LLC | 251,515 | $8,484,000 | 0.50% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 191,568 | $6,462,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 300,000 | $10,119,000 | 0.30% |
| EMERALD ADVISERS, LLC | 186,140 | $6,279,000 | 0.27% |